Nu-Med Plus, Inc. Announces Vice President of Medical Marketing...

Nu-Med Plus, Inc. Announces Vice President of Medical Marketing Discusses the Exciting Future of Nitric Oxide

Healthcare Tech Outlook | Friday, November 30, 2018

SALT LAKE CITY: Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Brett Earl, Vice President of Medical Marketing for Nu-Med Plus, recently spoke with The Life Science Report where he discussed  the many uses of nitric oxide and Nu-Med Pluss unique, low-cost delivery systems.

Dr. Brett Earl is Vice President of Medical Marketing for Nu-Med Plus and sits on its Board of Directors. He is a Board-Certified Emergency Physician with more than 15 years of experience in Emergency Medicine and more than a decade as a Functional Medicine Physician. He is currently the president and founder of Denali Medical Center. Dr. Earl received his medical degree from the University of Nevada- Reno. He has been published in numerous medical journals and serves on various medical boards in Utah

Jeff Robins CEO of Nu-Med Plus remarked, Nu-Med Plus, Inc. (NUMD: OTCQB.MKTS) uses a completely different method from any of the previous processes. That's why it's been able to be patented and has implications for uses from the hospital setting to Third-World countries. The technology is sophisticated, safe, well-designed and portable. And finally, it just is much more cost effective as far as getting it into the hands of medical professionals and patients that need it.

Inhaled nitric oxide is a medically essential gas that is currently used as a treatment for Neonate Hypoxia therapy (inadequate oxygen level in newborns), chronic obstructive pulmonary disease (COPD) and other pulmonary health issues. Precision doses of nitric oxide may have future applications for treating a variety of other diseases and complications that are currently being investigated. The Nu-Med Plus nitric oxide delivery products provide a portable, cost-effective, efficient, and user-friendly method of delivering precise therapeutic doses of nitric oxide to patients.

Weekly Brief